Printed in Great Britain
The Effect of Trypsin on the Formation of Virus-specific Surface Antigen in Cowpox Virus-infected Cells (Accepted 3 July I973) SUMMARY Poxvirus infection results in the production of virus-specific surface antigen (S-antigen) which is clearly distinguished from intra-cytoplasmic virus antigen (Vantigen) (Miyamoto & Kato, 1968, x97I ; Ueda, Ito &Tagaya, 1969) . In a study of the development of these antigens in several different established cell lines, we observed that some cells are relatively poor producers of S-and V-antigens and that in these cells treatment with trypsin markedly enhances S-antigen production but not V-antigen production.
The cells used in this work were HeLa (derived from human carcinoma of uterus), G2 (derived from human giant cell tumour of bone), THEL (derived from hamster lung) and VERO (derived from African green monkey kidney). They were cultured in Eagle's minimum essential medium (MEM) containing Io or 2 °/o calf serum. The LB-R strain of cowpox virus was prepared by treating infected cells in a sonifier, clarifying by centrifuging and then this was used to infect cells at an input multiplicity of I to 5 p.f.u./cell. Titrations of infectivity were made by plaque counts in VERO cells. Details of fluorescent antibody techniques for the detection of S-and V-antigens, employing cells infected in the presence or absence of cytosine arabinoside 2o/~g/ml, were as previously described (Ueda et al. 1969) . Stock trypsin (2 times crystallized, type I, Sigma Chem. Co., U.S.A.) was prepared in MEM. After treatment of cells or viruses, surviving trypsin activity was usually blocked by addition of soybean trypsin inhibitor (z times crystallized, type x, Sigma Chem. Co., U.S.A.) in a concentration equivalent to that of the trypsin (Gifford & Klapper, I967) .
Our initial observations revealed that, despite the use of comparable conditions, the numbers of S-and V-antigen positive cells were much lower in G2 and THEL cells than in HeLa or VERO cells (Table I) . Because poxvirus infection is known to be enhanced by treatment of either virus or cells with trypsin (Gifford & Klapper, I967, 1969; Kim, Dalton & Sharp, I969) , we investigated the effect of adding trypsin to the culture medium during the 2 h period of virus adsorption at 35 °C. This procedure significantly increased S-antigen production in all ceils but the effect was particularly marked in the poor antigen-producing cells, THEL (or G2), and relatively slight in VERO (or HeLa) cells (Table I and Fig. 1 (a) ). Under the same conditions V-antigen formation and virus adsorption, as measured by difference from unadsorbed virus infectivity, were unaffected ( Fig. I (b, c) ). The optimal concentration of trypsin for the enhancement of S-antigen formation was found to be o-I25 #g/ml in THEL and G2 cells, and o'5oo/g/ml in VERO and HeLa cells. Similar enhancement was achieved if either virus or cells was treated alone with trypsin before infection, though in this case the optimum concentration was o.25o/~g/ml for virus-treatment and o.o62/zg/ml for cell-treatment in THEL cells.
This effect of trypsin did not appear to be due to dispersion of virus particles, since virus which was treated in a sonifier for different periods gave no consistent enhancement. On the other hand, studies of the intracellular fate of input virus under the different conditions did reveal interesting differences. In these experiments intracellular infectivity at early times after infection was determined on cell sonicates obtained after the cells had been washed with virus antiserum. It was, therefore, a measure of virus which had adsorbed and penetrated but not yet been eclipsed. In the poor antigen-producing THEL cells there was a significantly greater accumulation of such virus than in VERO cells (Fig, 2) . Pre-treatment of the virus with trypsin reduced the level reached in THEL cells bringing it near to that seen in VERO cells. Attempts were also made to reproduce this kind of difference in vitro by exposing untreated and trypsin-treated virus to crude cell extracts at 37 °C. The cell extracts were prepared by homogenization and treatment in a sonifier of 8.8 × Io 7 cells in 2 ml MEM. Virus infectivity was lost to a greater extent in VERO cell extract than in THEL cell extract and pre-treatment with trypsin partially abolished this difference (Fig. 3) .
We believe that our results suggest that a cellular function required in the first stage of virus uncoating (Joklik, i968 ) is relatively inefficient in THEL and G2 cells. Trypsin facilitates virus uncoating in these cells and leads to an enhanced expression of the 'early' functions of the virus genome which are believed to include S-antigen production (Ueda et al. I969).
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